1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. BICARA THERAPEUTICS INC.

Bicara Therapeutics Inc.

XNAS: BCAX

Download real time

12.44 -1.06 (-7.85%)

55.70% Fall from 52W High

479.6K XNAS Volume

XNAS 18 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
1S
11W
4O
1T
676.9

Market Cap

Below industry Median
-

PE TTM

-

PEG TTM

1.3

Price to Book

Below industry Median
-

Beta 1Year



Insider Trading disclosures for Bicara Therapeutics Inc.

The latest disclosure was made by Kiran Mazumdar-Shaw in Bicara Therapeutics Inc. where a trade of 4,000,000 Series Seed Redeemable Convertible Preferred Stock done was reported to US exchanges on Sept. 12, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 4,000,000 0 - - Series Seed Redeemable Convertible Preferred Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 1,080,775 1,080,775 - 0 Common Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 4,327,365 4,443,122 - 0 Common Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 3,000,000 0 - - Series Seed Redeemable Convertible Preferred Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 9,990,144 0 - - Series Seed Redeemable Convertible Preferred Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 40,000,000 0 - - Series Seed Redeemable Convertible Preferred Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2024 23,746 23,746 - - Stock Option (Right to Buy)
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 432,736 432,736 - 0 Common Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 324,552 324,552 - 0 Common Stock
Jake Simson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2024 23,746 23,746 - - Stock Option (Right to Buy)
Scott Robertson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2024 23,746 23,746 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters